← FDA DRUG APPROVALS
FDA ANDA · ANDA212589
QUINIDINE GLUCONATE
quinidine gluonate
Sponsor: HIBROW HLTHCARE
APPLICATION
ANDA212589
TYPE
ANDA
ORIGINAL APPROVAL
2021-09-17
LATEST ACTION
2023-01-27
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
QUINIDINE GLUCONATEPrescription
QUINIDINE GLUCONATE 324MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2023-01-27Manufacturing (CMC) · Supplement 2 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.